Medical practitioner

This is an organization of doctors and nurses based in area offices and form the medical arm of the HSE. The EMAS provides advice, at the request of the employer, employee, self-employed, trade union representative or medical practitioner, on the effects of work on health. 

They have indications exclusively appropriate to traditional herbal medicinal products which, by virtue of their composition and purpose, are intended and designed for use without the supervision of a medical practitioner for diagnostic purposes or for prescription or monitoring of treatment. 

The investigations must be performed under the responsibility of a medical practitioner or other authorised qualified person (e.g. dentist). 

The name of the medical practitioner or other authorized person and of the institution responsible for the investigations... 

The collaboration between mental health services and members of families of people with mental illness and their other carers is of essential importance in developing a useful and successful mental health service. Collaboration with carers is not in existence in many of the Third World countries, and in places where it exists it is at present often restricted to a one-way communication of instruction of what the carers should do to assist in the realization of the treatment plan established by the medical practitioners. Advice from carers and information about the effects of treatment can both be of great value in the treatment of individual patients and in deciding the best use of medications and other treatments in health services in general. 

The bewildering host of new synthetic organic chemicals presents a variety of complex problems to the medical practitioner, many of which are entirely new to him. The basis for these problems lies in the lack of essential information about the many ways in which pesticides seem to influence physiologic function and the apparent indifference and carelessness with which many of these new and untried compounds are handled and used. 

In as much as products for the diagnosis and treatment of ocular disease cover the spectrum of practically all dosage forms and, thus, require the same pharmaceutical sciences for their development, in this chapter we discuss the entire scope of considerations involved in the development of ophthalmic products, ranging from regulatory and compendial requirements, through physicochemical, safety, and efficacy considerations, to a discussion of types of dosage forms currently used by the medical practitioner. 

Because of today s myriad regulations, the NDA submission has become a compilation of information that could be compared in size with any one of the well-known encyclopedias. Before 1962, only a few volumes were necessary for an NDA submission [11]. Today it is not uncommon for this justification to consist of as many as 200 volumes of information (see Table 2). It is important for the pharmacy and medical practitioner to have some sensitivity to the many requirements and high cost placed on manufacturers who develop and market new drugs (especially new drug substances) today. 

Gluckman, Laurie K. Faust the evidence that he was a medical practitioner. Medi theme 17, no. 4 (Nov 1998) 98-100. 

We gave patients suffering from irritable bowel syndrome three doses of a therapeutic relationship. The lowest dose was no relationship with the medical practitioner and no treatment at all. These patients were simply assessed and put on a waiting list, with the promise that they would receive treatment some... 

Eugene Dowdle. You have not mentioned the effects of Medical Aid schemes on physician-physician and physician-patient relationships. One of the keystones of the Oslerian ethic was the sense of collegiality that bound the medical profession and provided, indirectly, a form of peer review that was of benefit to both patients and to medical practitioners. Medical Aid schemes, by their monetarising effects, have done much to damage those professional bonds. 

Sodium nitroprusside (SNP), which is also known as Nipruss or Nipride to medical practitioners, was the first iron nitrosyl complex, prepared as far back as 1850 by Playfair [40]. The hypotensive property of SNP was first demonstrated by Johnson [41] in 1929. It was shown that application of a moderate dose of SNP reduces the blood pressure of a severely hypertensive patient without any side effect [42]. Since that time considerable research has been carried out to understand the mode of action of nitroprusside and its metabolic fate. SNP is now regarded as a potent vasodilator that causes muscle relaxation by releasing NO which activates the cytosolic isozyme of guanylyl cyclase [43-46]. 

Drug-related problem is not a major subject in most university programmes in medicine or pharmacy. When there is no specific course, there is often no book covering the topic. In our view, as teachers at various university courses, there has been a shortage of literature that reflects the most important aspects of drug-related problems in the elderly. Medical practitioners, nurses and pharmacists, need to have this knowledge to be able to serve their patients in the best way. 

Identifying the Most Important Laboratory Analytes to Monitor in a Clinical Trial. A choice often must be made among the numerous laboratory analytes that could be measured in a clinical trial. This choice is based on (1) past experience with the treatment(s) being evaluated, (2) therapeutic claim, (3) cost of the tests, (4) convenience of obtaining samples, (5) resources available, (6) state-of-the-art concept of the data s importance, and (7) the ability of data obtained to convince both regulators and medical practitioners. To arrive at a decision given these and other previously discussed factors may be difficult. 

Any dosage-form can produce adverse drug reactions. Hence, a regular feed back of relevant information on such adverse reactions from the medical practitioners to the appropriate regulatory authorities and the concerned manufacturers would not only help to intensify better safety measures but also widen the scope to improve drug-design by meticulous research scientists all over the world. 

Simultaneously with the elucidation of the tricarboxylic acid cycle was the discovery of the means by which oxygen was utilized in cells for terminal oxidation. An abortive start on this had been made by MacMunn (1886), a medical practitioner and the author of a major text on spectroscopy. In a paper for the Royal Society (1886) MacMunn had concluded ... 

Today, personnel from a myriad of fields are involved in the process of drug discovery and development, from scientists, clinicians, and medical practitioners to statisticians. Even persons from seemingly disparate occupations, such... 

A registered medical practitioner must certify the accuracy of the summary information. 

Advancement in autoimmune and inflammatory disease treatment and diagnosis represents a critical worldwide need ranking in importance only behind management of cardiovascular disease and cancer to the medical practitioner. The list of related diseases is long major classes include rheumatoid arthritis, asthma, diabetes type 1, multiple sclerosis, and inflammatory bowel disease. 

On the other hand, there is the desire to respect the clinical freedom of medical practitioners to determine the most appropriate treatment for their patients. 

A new device that is specifically made in accordance with a duly qualified medical practitioner s written prescription and which gives, under the practitioner s responsibility, specific design characteristics, and is intended for the sole use of a particular patient is permitted to be marketed without CE marking imder provisions referring to custom-made devices. The prescription may be made by any person authorised by virtue of their professional qualifications to do so. Mass produced devices that need to be adapted to meet the specific requirements of the medical practitioner or any other professional user are not considered to be custom-made devices. 

There are currently five clinical evaluation units within DSEB, each headed by a senior medical officer and supported by pharmacists. Applications are distributed among the five evaluation units based on the therapeutic area of the drug under evaluation. The DSEB contracts a number of external clinical evaluators who are specialist medical practitioners in the medical condition that the proposed new drug is intended to treat. External evaluators may also be contracted to evaluate the Module 4 data. The head of the clinical evaluation unit coordinates the evaluation and makes the final decision on marketing approval as a delegate under the Therapeutic Goods Act. 

---